|
Abbott Laboratories
cmv-specific antibodies Cmv Specific Antibodies, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cmv-specific antibodies/product/Abbott Laboratories Average 90 stars, based on 1 article reviews
cmv-specific antibodies - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Abbott Laboratories
sirolimus abbott cmia Sirolimus Abbott Cmia, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/sirolimus abbott cmia/product/Abbott Laboratories Average 90 stars, based on 1 article reviews
sirolimus abbott cmia - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Abbott Laboratories
chemiluminescence marker (cmia) Chemiluminescence Marker (Cmia), supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/chemiluminescence marker (cmia)/product/Abbott Laboratories Average 90 stars, based on 1 article reviews
chemiluminescence marker (cmia) - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Abbott Laboratories
cmia for total anti-hbc and anti-hbc igm ![]() Cmia For Total Anti Hbc And Anti Hbc Igm, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cmia for total anti-hbc and anti-hbc igm/product/Abbott Laboratories Average 90 stars, based on 1 article reviews
cmia for total anti-hbc and anti-hbc igm - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Abbott Laboratories
chemiluminescent microparticle cmv-igg immunoassay abbott architect ![]() Chemiluminescent Microparticle Cmv Igg Immunoassay Abbott Architect, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/chemiluminescent microparticle cmv-igg immunoassay abbott architect/product/Abbott Laboratories Average 90 stars, based on 1 article reviews
chemiluminescent microparticle cmv-igg immunoassay abbott architect - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Abbott Laboratories
cmia assays ![]() Cmia Assays, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cmia assays/product/Abbott Laboratories Average 90 stars, based on 1 article reviews
cmia assays - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Abbott Laboratories
chemiluminescent microparticle immunoassay cmia ![]() Chemiluminescent Microparticle Immunoassay Cmia, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/chemiluminescent microparticle immunoassay cmia/product/Abbott Laboratories Average 90 stars, based on 1 article reviews
chemiluminescent microparticle immunoassay cmia - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Abbott Laboratories
cmia ![]() Cmia, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cmia/product/Abbott Laboratories Average 90 stars, based on 1 article reviews
cmia - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Abbott Laboratories
cmia abbott ![]() Cmia Abbott, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cmia abbott/product/Abbott Laboratories Average 90 stars, based on 1 article reviews
cmia abbott - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Pfizer Inc
cmia ![]() Cmia, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cmia/product/Pfizer Inc Average 90 stars, based on 1 article reviews
cmia - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Abbott Laboratories
anti-cmv igg chemiluminescent microparticle immunoassay (cmia) ![]() Anti Cmv Igg Chemiluminescent Microparticle Immunoassay (Cmia), supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti-cmv igg chemiluminescent microparticle immunoassay (cmia)/product/Abbott Laboratories Average 90 stars, based on 1 article reviews
anti-cmv igg chemiluminescent microparticle immunoassay (cmia) - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Abbott Laboratories
hbeag cmia kit 06c3237 ![]() Hbeag Cmia Kit 06c3237, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/hbeag cmia kit 06c3237/product/Abbott Laboratories Average 90 stars, based on 1 article reviews
hbeag cmia kit 06c3237 - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Viruses
Article Title: Clinical Utility of Quantitative HBV Core Antibodies for Solving Diagnostic Dilemmas
doi: 10.3390/v15020373
Figure Lengend Snippet: Methods and units used for anti-HBc antibodies quantitation.
Article Snippet:
Techniques: Quantitation Assay, Sandwich ELISA
Journal: PLOS Pathogens
Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection
doi: 10.1371/journal.ppat.1012624
Figure Lengend Snippet: Peripheral blood samples obtained from the patient on the days indicated were tested by the quantitative Abbott Anti-RBD-CMIA (a) and the GenScript cPass sVNT (b) . Antibody levels detected by Anti-RBD-CMIA and sVNT are given as arbitrary units (AU)/mL, cut-off ≥50 AU/mL, and signal reduction (% inhibition, cut-off >30%) as compared to the negative control. The GenScript cPass sVNT was performed with technical duplicates at a serum dilution of 1:20. The cut-off of the sVNT is indicated by the horizontal dotted line. (c) Qualitative results of the Mikrogen line blot testing for Anti-N IgG, as well as Anti-S1 and Anti-RBD IgM and IgG, are indicated as follows: open squares: non-reactive, grey squares: reactive below cut-off, black squares: reactive above cut-off. Administration of bamlanivimab (B), first vaccination (V) and therapy with sotrovimab (S) is indicated by vertical dotted lines.
Article Snippet: IgG antibodies against the nucleocapsid (N) protein were not detected in
Techniques: Inhibition, Negative Control
Journal: Analytical Biochemistry
Article Title: A review post-vaccination SARS-CoV-2 serological test: Method and antibody titer response
doi: 10.1016/j.ab.2022.114902
Figure Lengend Snippet: Several methods of postvaccine SARS-Cov-2 serological tests have been reported.
Article Snippet:
Techniques: Enzyme-linked Immunosorbent Assay, Immunofluorescence, Modification
Journal: Nature Communications
Article Title: Hepatitis B virus rigs the cellular metabolome to avoid innate immune recognition
doi: 10.1038/s41467-020-20316-8
Figure Lengend Snippet: a PHHs were infected with or without HBV virions (MOI = 30) for 9 days and harvested for metabolomics analysis. A heat map shows changes of glycolysis or oxidative phosphorylation metabolites. b Quantification of indicated intermediates of glycolysis and TCA cycle. c Simplified scheme of the glucose metabolic pathway. d , e PHHs were infected with or without HBV virions (MOI = 30) for 7 days. The supernatants were pretreated with or without anti-HBs, an HBV neutralizing antibody. Then, cells were cultured with high glucose (25 mM) or low glucose (5 mM) for 36 h, and treated with or without poly(I:C) (1 μg/mL) for 12 h prior to qPCR analyses. f , g Experiments were performed similar to those in d , e , except that cells were treated with or without HTDNA (1 μg/mL) or LPS (50 ng/mL). h C57BL/6 mice received HI with 10 µg of plasmid pAAV-HBV1.2 for 7 days. Mice were fasted overnight and then treated with high glucose (1.5 g/kg) or low glucose (0.2 g/kg) and were treated with PBS or poly(I:C) (10 μg/g) for 2 days (left panel). Mouse liver samples were collected and subjected to qPCR analyses (right panel). i IRNAR1 expression in IFNAR1 WT (WT) and IFNAR1−/− cells was measured using RT-PCR and western blot analyses. j IFNAR1 WT (WT) and IFNAR1−/− cells were cultured with high glucose or low glucose and transfected with pHBV-1.3 for 48 h. HBsAg and HBeAg (middle panel) secreted in culture supernatants were quantified by chemiluminescence immunoassay (CMIA), or HBV genomes in culture supernatants were determined by qPCR. k IFNAR expression in liver ( n = 3) was measured using RT-PCR and western blot analyses. l Experiments were performed similar to those in h , except HBsAg, HBeAg and HBV DNA were analyzed. Data b , d – g , j represent the means ± SD (Student’s t test), data h , j , l represent the means ± SEM (one-way ANOVA) (** P < 0.01; * P < 0.05, n.s., not significant). S:CO signal to cutoff ratio, HG high glucose, LG low glucose, HI hydrodynamic injection. See also Supplementary Figs. and .
Article Snippet: The levels of secreted HBsAg and HBeAg were determined using the Architect System and HBsAg and
Techniques: Infection, Phospho-proteomics, Cell Culture, Plasmid Preparation, Expressing, Reverse Transcription Polymerase Chain Reaction, Western Blot, Transfection, Chemiluminescence Immunoassay, Injection
Journal: Nature Communications
Article Title: Hepatitis B virus rigs the cellular metabolome to avoid innate immune recognition
doi: 10.1038/s41467-020-20316-8
Figure Lengend Snippet: a PHHs were infected with HBV (MOI = 30) for 8 days and treated with or without UK5099 (10 μM) for 12 h. HBsAg (left panel) and HBeAg (middle panel) secreted in culture supernatants were quantified using CMIA, or the levels of HBV genomes in culture supernatants were determined using qPCR (right panels). b PHHs were infected with or without HBV virions (MOI = 30) for 8 days, and transfected with or without poly(I:C) (1 μg/mL), treated with or without UK5099 (10 μM) for 12 h, and subjected to qPCR analyses for IFN-β. c , d Experiments were performed as in a and b , except that PHHs were treated with or without DCA (10 mM) for 12 h. e , f Experiments were performed as in a , b , except that PHHs were exposed to normoxia (20% O 2 ) or hypoxia (1% O 2 ) for 12 h. g , h Experiments were performed as in a , b , except that PHHs were cultured in mediums containing glucose (25 mM) or galactose (25 mM) for 12 h. All data represent the means ± SD (Student’s t test) (** P < 0.01; * P < 0.05, n.s., not significant). S:CO signal to cutoff ratio. See also Supplementary Figs. .
Article Snippet: The levels of secreted HBsAg and HBeAg were determined using the Architect System and HBsAg and
Techniques: Infection, Transfection, Cell Culture
Journal: Nature Communications
Article Title: Hepatitis B virus rigs the cellular metabolome to avoid innate immune recognition
doi: 10.1038/s41467-020-20316-8
Figure Lengend Snippet: a HepG2-NTCP cells were infected with or without HBV virions (MOI = 300) for 3 days, and transfected the indicated plasmids or shRNAs for 48 h. HBsAg (left panel) and HBeAg (right panel) secreted in culture supernatants were quantified using CMIA. b , c Experiments were performed as in a , except the levels of HBV genomes in culture supernatants were determined using qPCR ( b ), or lactate secretion in supernatants was analyzed ( c ). d HepG2-NTCP cells were infected with or without HBV virions (MOI = 300) for 3 days. Cells were transfected with the indicated plasmids or shRNAs for 36 h, and transfected with or without poly(I:C) (1 μg/mL) for 12 h, and subjected to qPCR (left panel) and ELISA (right panel) analyses. e – h Experiments were performed as in a – d , except sh-LDHAs were used. i HepG2-NTCP cells were infected with or without HBV virions (MOI = 300) for 3 days and treated with or without sodium oxamate for 24 h. HBsAg (left panel) and HBeAg (right panel) secreted in culture supernatants were quantified by CMIA. j , k Experiments were performed as in i , except the levels of HBV genomes in culture supernatants were determined using qPCR ( j ), or the lactate secretion in the supernatant was analyzed ( k ). l HepG2-NTCP cells were infected with or without HBV virions (MOI = 300) for 3 days and treated with or without sodium oxamate. Twelve hours later, cells were transfected with or without poly(I:C) (1 μg/mL) for 12 h, and were subjected to qPCR (left panel) and ELISA (right panel) analyses. m – o Experiments were performed as in i , j , l , except lactate was used. All data represent the means ± SD (Student’s t test) (** P < 0.01; * P < 0.05, n.s., not significant). S:CO signal to cutoff ratio, Oxa oxamate, Lac lactate. See also Supplementary Fig. .
Article Snippet: The levels of secreted HBsAg and HBeAg were determined using the Architect System and HBsAg and
Techniques: Infection, Transfection, Enzyme-linked Immunosorbent Assay
Journal: Nature Communications
Article Title: Hepatitis B virus rigs the cellular metabolome to avoid innate immune recognition
doi: 10.1038/s41467-020-20316-8
Figure Lengend Snippet: a – d C57BL/6 mice ( n = 5 for each group) received HI with 10 µg of plasmid pAAV-HBV1.2. At 7 days after HI, the mice were treated with high glucose (1.5 g/kg) or low glucose (0.2 g/kg) with or without injection of sodium oxamate (750 mg/kg) for 2 days ( a ). Serum HBsAg and HBeAg were analyzed using CMIA ( b ). Serum HBV DNA was quantified by qPCR ( c ). HBV replicative intermediates in liver tissues were extracted and detected by Southern blotting ( d ). e – h Experiments were performed as in a – d , except sodium lactate (1 g/kg) was used. i – l Experiments were performed similar as in a – d , except sodium oxamate (750 mg/kg) and sodium lactate (1 g/kg) were used. m – p WT ( n = 5) and IFNAR −/− ( n = 5) mice received HI with 10 µg of plasmid pAAV-HBV1.2. At 7 days after HI, the mice were treated with high glucose (1.5 g/kg) or low glucose (0.2 g/kg) for 2 days ( m ). Serum HBsAg and HBeAg were analyzed using CMIA ( n ). Serum HBV DNA was quantified by qPCR ( o ). HBV replicative intermediates in liver tissues were extracted and detected by Southern blotting ( p ). q – t Experiments were performed as in m – p , except sodium oxamate (750 mg/kg) was used. u – x Experiments were performed as in m – p , except sodium lactate (1 g/kg) was used. Data in b , c , f , g , j , k , n , o , r , s v , w represent means ± SEM (one-way ANOVA) (** P < 0.01; * P < 0.05, n.s., not significant). See also Supplementary Fig. .
Article Snippet: The levels of secreted HBsAg and HBeAg were determined using the Architect System and HBsAg and
Techniques: Plasmid Preparation, Injection, Southern Blot